TY - JOUR
T1 - Management of involved or close resection margins in 120 patients with colorectal liver metastases
T2 - edge cryotherapy can achieve long-term survival
AU - Yan, Tristan D.
AU - Padang, Ratnasari
AU - Xia, Hong
AU - Zhao, Jing
AU - Li, Jie
AU - Morris, David L.
PY - 2006/6
Y1 - 2006/6
N2 - Background: The liver resection margin is prognostically significant for patients with colorectal liver metastases. Management plans for patients with suboptimal resection margins have not been adequately addressed. This article reports the long-term results of edge cryotherapy in 120 patients with suboptimal resection margins. Methods: A retrospective analysis of prospectively collected clinical data of 120 patients with suboptimal hepatic resection margins was performed. Morbidity, mortality, recurrence, and survival results were analyzed. Results: The median length follow-up was 30 months (range 1 to 139). The median disease-free interval was 19 months (range 2 to 139). Cryosite, remaining liver, and extrahepatic recurrence rates were 10%, 36%, and 47%, respectively. The median survival was 39 months (range 1 to 139), and 1-, 3-, and 5-year survival rates were 89%, 55%, and 36%, respectively. Cryosite and extrahepatic recurrence were independently associated with a reduced survival outcome. Comments: Edge cryotherapy to suboptimal liver resection margins can achieve a lower local recurrence rate and a longer survival advantage.
AB - Background: The liver resection margin is prognostically significant for patients with colorectal liver metastases. Management plans for patients with suboptimal resection margins have not been adequately addressed. This article reports the long-term results of edge cryotherapy in 120 patients with suboptimal resection margins. Methods: A retrospective analysis of prospectively collected clinical data of 120 patients with suboptimal hepatic resection margins was performed. Morbidity, mortality, recurrence, and survival results were analyzed. Results: The median length follow-up was 30 months (range 1 to 139). The median disease-free interval was 19 months (range 2 to 139). Cryosite, remaining liver, and extrahepatic recurrence rates were 10%, 36%, and 47%, respectively. The median survival was 39 months (range 1 to 139), and 1-, 3-, and 5-year survival rates were 89%, 55%, and 36%, respectively. Cryosite and extrahepatic recurrence were independently associated with a reduced survival outcome. Comments: Edge cryotherapy to suboptimal liver resection margins can achieve a lower local recurrence rate and a longer survival advantage.
KW - Colorectal liver metastasis
KW - Edge cryotherapy
KW - Hepatic cryotherapy
KW - Liver resection
UR - http://www.scopus.com/inward/record.url?scp=33646582646&partnerID=8YFLogxK
U2 - 10.1016/j.amjsurg.2005.05.055
DO - 10.1016/j.amjsurg.2005.05.055
M3 - Article
C2 - 16720141
AN - SCOPUS:33646582646
VL - 191
SP - 735
EP - 742
JO - American Journal of Surgery
JF - American Journal of Surgery
SN - 0002-9610
IS - 6
ER -